Evaluation of HLA-G immune checkpoint molecule in melanocytic lesions
ABSTRACT The human leukocyte antigen-G (HLA-G) is a non-classical molecule of the major histocompatibility complex. HLA-G has been associated with the process of tumorigenesis and tumor escape. In this study, we aim to evaluate the HLA-G expression in melanocytic lesions and in melanoma for determining when melanocytic lesions start its expression. Twenty-two skin biopsies samples were submitted to immunohistochemistry; HLA-G expression was detected in 63.6% of the samples. This expression in melanocytic cells was significantly higher in melanoma than in benign melanocytic lesions (p < 0.002). Our results suggest that HLA-G expression starts late in the process of tumorigenesis.
Main Authors: | , , , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Brasileira de Patologia Clínica
2020
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442020000100600 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S1676-24442020000100600 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S1676-244420200001006002020-05-06Evaluation of HLA-G immune checkpoint molecule in melanocytic lesionsGomes,Raylane PCaetano,Gabriela TayrineSampaio,Lucas Henrique FSilva,Camila RCosta,Maurício BCysneiro,Maria AuxiliadoraWastowski,Isabela Jubé melanoma HLA-G antigens immunohistochemistry ABSTRACT The human leukocyte antigen-G (HLA-G) is a non-classical molecule of the major histocompatibility complex. HLA-G has been associated with the process of tumorigenesis and tumor escape. In this study, we aim to evaluate the HLA-G expression in melanocytic lesions and in melanoma for determining when melanocytic lesions start its expression. Twenty-two skin biopsies samples were submitted to immunohistochemistry; HLA-G expression was detected in 63.6% of the samples. This expression in melanocytic cells was significantly higher in melanoma than in benign melanocytic lesions (p < 0.002). Our results suggest that HLA-G expression starts late in the process of tumorigenesis.info:eu-repo/semantics/openAccessSociedade Brasileira de Patologia Clínica Jornal Brasileiro de Patologia e Medicina Laboratorial v.56 20202020-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442020000100600en10.5935/1676-2444.20200016 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Gomes,Raylane P Caetano,Gabriela Tayrine Sampaio,Lucas Henrique F Silva,Camila R Costa,Maurício B Cysneiro,Maria Auxiliadora Wastowski,Isabela Jubé |
spellingShingle |
Gomes,Raylane P Caetano,Gabriela Tayrine Sampaio,Lucas Henrique F Silva,Camila R Costa,Maurício B Cysneiro,Maria Auxiliadora Wastowski,Isabela Jubé Evaluation of HLA-G immune checkpoint molecule in melanocytic lesions |
author_facet |
Gomes,Raylane P Caetano,Gabriela Tayrine Sampaio,Lucas Henrique F Silva,Camila R Costa,Maurício B Cysneiro,Maria Auxiliadora Wastowski,Isabela Jubé |
author_sort |
Gomes,Raylane P |
title |
Evaluation of HLA-G immune checkpoint molecule in melanocytic lesions |
title_short |
Evaluation of HLA-G immune checkpoint molecule in melanocytic lesions |
title_full |
Evaluation of HLA-G immune checkpoint molecule in melanocytic lesions |
title_fullStr |
Evaluation of HLA-G immune checkpoint molecule in melanocytic lesions |
title_full_unstemmed |
Evaluation of HLA-G immune checkpoint molecule in melanocytic lesions |
title_sort |
evaluation of hla-g immune checkpoint molecule in melanocytic lesions |
description |
ABSTRACT The human leukocyte antigen-G (HLA-G) is a non-classical molecule of the major histocompatibility complex. HLA-G has been associated with the process of tumorigenesis and tumor escape. In this study, we aim to evaluate the HLA-G expression in melanocytic lesions and in melanoma for determining when melanocytic lesions start its expression. Twenty-two skin biopsies samples were submitted to immunohistochemistry; HLA-G expression was detected in 63.6% of the samples. This expression in melanocytic cells was significantly higher in melanoma than in benign melanocytic lesions (p < 0.002). Our results suggest that HLA-G expression starts late in the process of tumorigenesis. |
publisher |
Sociedade Brasileira de Patologia Clínica |
publishDate |
2020 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442020000100600 |
work_keys_str_mv |
AT gomesraylanep evaluationofhlagimmunecheckpointmoleculeinmelanocyticlesions AT caetanogabrielatayrine evaluationofhlagimmunecheckpointmoleculeinmelanocyticlesions AT sampaiolucashenriquef evaluationofhlagimmunecheckpointmoleculeinmelanocyticlesions AT silvacamilar evaluationofhlagimmunecheckpointmoleculeinmelanocyticlesions AT costamauriciob evaluationofhlagimmunecheckpointmoleculeinmelanocyticlesions AT cysneiromariaauxiliadora evaluationofhlagimmunecheckpointmoleculeinmelanocyticlesions AT wastowskiisabelajube evaluationofhlagimmunecheckpointmoleculeinmelanocyticlesions |
_version_ |
1756427560003043328 |